Table 2.
Quality assessment ratings for the included studies
| Author | Ross | Salinger | Long | Abosch | Freda | Swearingen | Biermasz | Pollock | Acosta-Gomez | Landolt | Petit | Jagannathan | Losa | Yamada | Albarel | Van Rompaey | Sankhla | Shirvani | Sun | Sinha | Paluzzi | Losa | Ismail |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Were there clear criteria for inclusion in the case series? | Y | N | Y | Y | U | Y | Y | Y | N | Y | N | Y | Y | N | Y | Y | N | U | Y | Y | N | Y | Y |
| Was the condition measured in a standard, reliable way for all participants included in the case series? | Y | U | Y | Y | Y | Y | Y | Y | U | U | U | Y | Y | Y | Y | Y | N | Y | U | Y | Y | N | N |
| Were valid methods used for identification of the condition for all participants included in the case series? | U | U | Y | U | U | U | Y | Y | U | U | Y | Y | U | Y | Y | N | N | N | N | Y | N | Y | U |
| Was there clear reporting of the demographics of the participants in the study? | N | N | Y | N | N | N | N | N | N | Y | N | N | N | N | N | N | N | N | N | N | N | N | N |
| Was there clear reporting of clinical information of the participants? | Y | Y | Y | Y | Y | U | Y | Y | Y | Y | Y | Y | Y | Y | U | U | Y | U | Y | Y | Y | Y | U |
| Were the outcomes or follow up results of cases clearly reported? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Was there clear reporting of the presenting site(s)/clinic(s) demographic information? | N | N | N | N | N | N | N | N | N | N | N | N | N | N | N | N | N | N | N | N | N | N | N |
N No, Y Yes, U Unclear